Compare ARK Genomic Revolution ETF (ARKG) vs Ford Motor Company (F) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Ford Motor Company — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while Ford Motor Company trades at $13.96 (market cap $55.79B). The key difference: Ford Motor Company pays a 4.29% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Ford Motor Company nearer its low. Which is the better fit depends on your goals.
| ARKG | F | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $17.44 |
52-Week Low | $23.09 | $10.82 |
Market Cap | — | $55.79B |
Enterprise Value | — | $184.81B |
Dividend Yield | — | 4.29% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Ford (F) trades at $13.995, up 2.83% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative net income margin and ROE. Recent developments include a tentative labor agreement in Canada and JD Power quality recognition, though vehicle recalls and declining EV sales present headwinds.
Ford's valuation appears attractive with low P/E and P/S ratios, but fundamental weakness in profitability and rising debt levels warrant caution. Analyst consensus leans neutral with $14.89 price target, while institutional sentiment shows divided opinions. The stock offers value potential if operational improvements materialize, but execution risks and competitive pressures remain significant concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Ford Motor Company
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →
